Emily S. Singer
Papers
4
Total Citations
234
H-Index
4
About
Emily S. Singer is a leading health services researcher whose work sits at the critical intersection of surgical innovation, health economics, and patient-centered outcomes in thoracic oncology. Her primary research focus is evaluating the real-world value of robotic-assisted surgery for lung cancer, specifically comparing its clinical effectiveness and financial costs against traditional video-assisted thoracoscopic (VATS) and open lobectomy. Singer’s most impactful contribution is her landmark 2019 propensity score–weighted comparison (133 citations), which provided crucial evidence on the trade-offs between robotic and other surgical approaches. She further advanced this field by demonstrating that postoperative complications significantly erode the cost-effectiveness of robotic lobectomy (21 citations), a finding with direct implications for hospital resource allocation. Singer also champions patient-reported outcomes, as shown in her 2020 review on quality of life after lung cancer resection (19 citations), ensuring that surgical decisions are informed by what matters most to patients. Her work, with over 230 total citations, provides the rigorous, data-driven framework necessary for hospitals and surgeons to navigate the high-stakes decision of adopting costly new technologies in an era of value-based care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4